Below are the financial statements of Moderna, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | — | — | — |
| Net product sales | 3.11a | 6.67a | 18.44a |
| Other revenue | 0.13a | 0.18a | 0.83a |
| Total revenue | 3.24a | 6.85a | 19.26a |
| Operating expenses | — | — | — |
| Cost of sales | -1.46a | -4.69a | -5.42a |
| Research and development | -4.54a | -4.85a | -3.3a |
| Selling, general and administrative | -1.17a | -1.55a | -1.13a |
| Total operating expenses | -7.18a | -11.09a | -9.84a |
| (Loss) income from operations | -3.95a | -4.24a | 9.42a |
| Interest income | 0.43a | 0.42a | 0.2a |
| Other expense, net | -0.09a | -0.12a | -0.05a |
| (Loss) income before income taxes | -3.61a | -3.94a | 9.58a |
| (Benefit from) provision for income taxes | -0.05a | 0.77a | 1.21a |
| Net (loss) income | -3.56a | -4.71a | 8.36a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Moderna’s data sources below and access millions more through our Disclosure Search.